Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

313.82 +4.41 (+1.43%)
Official Closing Price Updated: 7:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today ↗
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of... 
Via Benzinga
News headline image
Cardinal Health Earnings: Can Perfection Get Priced In Twice? ↗
Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend. 
Via MarketBeat
Topics World Trade
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Cencora (COR) Q3 2026 Earnings Call Transcript ↗
Revenue hit $84.8 billion as GLP-1 sales surged 25% despite manufacturer price headwinds. 
Via The Motley Fool
Topics Earnings
Cencora (NYSE:COR) Shares Tick Up as Fiscal Q3 Results Meet Estimates, Full-Year Guidance Adjusted ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Wednesday? ↗
Via Chartmill
News headline image
5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call
Cencora’s second quarter was marked by performance that met Wall Street’s expectations on revenue and exceeded consensus on non-GAAP profitability, driving a... 
Via StockStory
Topics Earnings
News headline image
Cencora Q3 Earnings Call Highlights ↗
Cencora (NYSE:COR) reported fiscal 2026 third-quarter results marked by double-digit adjusted operating income growth, specialty-business momentum and $1 billion in share repurchases, prompting the... 
Via MarketBeat
Topics ETFs Earnings
News headline image
COR Q2 Deep Dive: Specialty Platform and MSO Growth Propel Steady Healthcare Distribution
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAA... 
Via StockStory
Which S&P500 stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
Cencora’s (NYSE:COR) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAA... 
Via StockStory
News headline image
Cencora Reports Fiscal 2026 Third Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Earnings: What To Look For From COR
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. Cencora missed analyst... 
Via StockStory
Topics Artificial Intelligence
News headline image
McKesson's Compounding Keeps Adding Up ↗
McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix. 
Via MarketBeat
News headline image
Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Cencora (NYSE:COR) and its pe... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
3 Market-Beating Stocks for Long-Term Investors
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ... 
Via StockStory
News headline image
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
From Cencora
Via Business Wire
News headline image
2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m... 
Via StockStory
Topics Economy
News headline image
3 Big Reasons to Love Cencora (COR)
Over the past six months, Cencora’s stock price fell to $287.06. Shareholders have lost 15.8% of their capital, which is disappointing considering the S&P 50... 
Via StockStory
Topics Stocks Supply Chain
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Cencora Announces Samantha Hammock as Chief Human Resources Officer
From Cencora
Via Business Wire
News headline image
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now ↗
Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now. 
Via The Motley Fool
Topics Economy
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
From Pomerantz LLP
Via GlobeNewswire
News headline image
Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
From Cencora
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
From Pomerantz LLP
Via GlobeNewswire
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
Cencora Announces Updated Fiscal Year 2026 Financial Outlook
From Cencora
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
From Pomerantz LLP
Via GlobeNewswire
News headline image
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.